E B Ryan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E B Ryan

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Oral Oncology|October 1, 2023

Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.

Oral Oncology|October 2, 2024

Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancerAlice Dawson, Amir Hossein Karimi, Mushfiq H Shaikh, et al.

Ebiomedicine|November 28, 2022

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Oral Oncology|October 1, 2023

Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.

Oral Oncology|October 2, 2024

Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancerAlice Dawson, Amir Hossein Karimi, Mushfiq H Shaikh, et al.

Ebiomedicine|November 28, 2022

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.

Pageof 4